Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, Francesca Rocchio, Valentina Tini, Barbara Bigerna, Paolo Sportoletti, Simona Caruso, Andrea Marra, Sara Peruzzi, Eleonora Petito, Giulio Spinozzi, Sharon Shacham, Yosef Landesman, Concetta Quintarelli, Paolo Gresele, Franco Locatelli, Maria Paola Martelli, Brunangelo Falini, Lorenzo Brunetti

Journal title: Blood Advances

Journal publisher: Elsavier

Published year: 2022

DOI identifier: 10.1182/bloodadvances.2022007563

ISSN: 2473-9529